RESEARCH

 

 

For Kingfisher Health (KFHealth) was scientific research the essential basis for the development and continuous improvement of our products. The following studies have been carried out:

 

KFH ENERGY

 

THE METIPP CLINICAL STUDY, WHICH EXAMINED THE EFFICACY OF M.E.T. THERAPY WITH THE KFH ENERGY IN POST-POLIO PATIENTS.

The very first clinical study immediately showed excellent results in post-polio patients. For Post-Polio Syndrome (PPS) patients, as for many other patients, fatigue is one of the main reasons for reduced quality of life – several studies report that more than 85% of PPS patients experience paralyzing and unusual fatigue. The reasons are:

  • Altered muscle fibre composition: almost excluding white muscle cells (type 1 muscle fibres), which are hypertrophic (much larger than normal). This type of muscle fibre can release a lot of energy for a short time, but consumes a lot of energy and is therefore quickly acidified (tired).
  • The muscle strength often turns out to be more or less normal, but the muscles get tired quickly and recovery is slow. Moreover, the fibres work abnormally hard because they contract in an ‘all or nothing’ way, as opposed to addressing only those fibres that are required for a specific task.
  • There is substantial evidence that PP patients have an energy shortage in their muscles. High energy consumption and low energy synthesis, i.e. an energy imbalance, have been shown in several studies.
    The results of the research are quite impressive:
        A consistent and statistically significant reduction of 34% in the total fatigue score was found. These results were clearly reflected in the other observations of fatigue: the worst fatigue level, as well as the level of disturbance in daily life.
            Also in the field of endurance, a consistent and statistically significant improvement was observed: a 40% increase in endurance. If we group patients by answer category, we see that only 1 in 5 patients did not make any progress.
                Reduction of 34% in the total pain score was observed. About 7 out of 10 patients observed an improvement, and 3 out of 10 had no reduction in pain. 

                   

                   

                   Participating centres: Hasselt University.

                   

                  THE BESTIMS CLINICAL STUDY, WHICH INVESTIGATED THE EFFICACY OF M.E.T. THERAPY WITH KFH ENERGY IN MULTIPLE SCLEROSIS (MS) PATIENTS.

                  The second clinical study with Multiple-Sclerosis (MS) patients also shows positive results that are entirely in line with the above: MS patients can continue to walk and are less tired after M.E.T. therapy. This means that their fatigue has decreased and their stamina has increased, despite no improvement in muscle strength.

                  Participating centres: Hasselt University.

                   

                  THE DOMS CLINICAL STUDY, THIS INVESTIGATED THE EFFECTIVENESS OF M.E.T THERAPY WITH THE KFH ENERGY IN ATHLETES.

                  The research showed that recovery of muscle strength happened 2x as fast with KFH ENERGY. Also, the patients had less pain.

                  • Randomized, double blind, placebo controlled
                  • 16 healthy volunteers (male, 18 – 25 yrs, BMI ~ 25)
                  • Right quadriceps fatigued until exhaustion ( isokinetic dynamometer)
                  • MET/placebo treatment for 2 hrs per day (1 hr am, 1 hr pm) for 5 days
                  • Objectives :
                    • effect of bio-electrical stimulation therapy after intense eccentric exercise on
                      • Muscle strength recovery
                      • Muscle soreness
                      • Pain
                      • CK concentration
                    • Results
                      • Muscle strenght recovery is twice as fast with MET than placebo (significant result, p< 0,05)
                      • Pain & CK concentration are consistenly much lower in MET group versus control, but small sample size precludes statistical significance
                  • Efficacy
                    • significantly better revalidation compared to control
                    • lower CK-values versus control
                    • Potential for cheap and effective treatment and/or prevention
                  • Safety
                    • No known side effects
                    • Simple,  for home use
                    • No interference with conventional therapies
                    • Non-pharmaceutical

                  Participating centers / institutions: University of Hasselt

                   

                  KFH NOVO

                   

                  THE ULTRA-BEST CLINICAL STUDY, THIS EXAMINED THE EFFICACY OF M.E.T. THERAPY WITH THE KFH ENERGY IN KFH NOVO IN CHRONIC VENOUS ULCERS.

                  Participating centres: UZ Gasthuisberg, UZ Brussel, Virga Jesse Hospital Hasselt, CHU Liège, UZ Gent.

                  There are also several case studies.

                  The effect of M.E.T. on fatigue and resistance can be explained, but the mechanism behind the reduction of pain is more difficult to understand. In places of micro-damage or overexploitation, ATP stocks may decrease, thus explaining the positive effects of M.E.T. Other mechanisms could be the prevention of inflammatory cytokines or the known regenerative and healing effects of M.E.T. on cellular tissue. M.E.T. is also known to reduce pain in other conditions, such as postoperative numbness and more chronic conditions such as spinal cord injuries.

                  Would you like more information about the KFHealth studies? E-mail is also possible: research@kfhealth.eu

                   

                  KFH ENERGY RECOVERS THE PHYSIOLOGICAL CELL BALANCE!

                   

                  SHOP NOW